ARTICLE | Company News
Lantibio, TRB Chemedica, Alcon Laboratories Inc. deal
November 12, 2007 8:00 AM UTC
Lantibio and TRB granted Alcon exclusive U.S. rights to commercialize Vismed to treat dry eye syndrome. The aqueous solution of sodium hyaluronate is in Phase III testing for the indication. Lantibio...